SLG
NCIT

Stanley-Laman Group’s NCI, Inc. NCIT Stock Holding History

Stanley-Laman Group’s Portfolio NCIT Stock Details NCIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-31,823
Closed -$671K – 221
2017
Q2 		$671K Sell
31,823
-1,172
-4% -$20.1K 0.18% 114
2017
Q1 		$497K Sell
32,995
-2,069
-6% -$29.1K 0.13% 169
2016
Q4 		$489K Buy
35,064
+21,735
+163% +$274K 0.15% 182
2016
Q3 		$154K Buy
13,329
+700
+6% +$8.75K 0.06% 238
2016
Q2 		$177K Sell
12,629
-886
-7% -$12.2K 0.07% 240
2016
Q1 		$189K Sell
13,515
-3,930
-23% -$53.3K 0.04% 260
2015
Q4 		$238K Sell
17,445
-258
-1% -$3.85K 0.04% 289
2015
Q3 		$235K Buy
+17,703
New +$223K 0.05% 277

Stanley-Laman Group's NCIT Position: Q3 2017 in Review

Stanley-Laman Group sold out of NCI, Inc. (NCIT) in Q3 2017, closing a stake of 31,823 shares — an estimated $671K sold.

Stanley-Laman Group first reported a position in NCIT in Q3 2015 and held it in 8 quarters. The position peaked at $671K in Q2 2017. 0 funds tracked by Wall St. Rank hold NCIT as of Q3 2017.

  • Stanley-Laman Group reported no remaining NCI, Inc. position as of Q3 2017 after selling out during the quarter.
  • Stanley-Laman Group sold 31,823 NCI, Inc. shares in Q3 2017, an estimated $671K.
  • Stanley-Laman Group first reported a position in NCI, Inc. in Q3 2015 and held it in 8 quarters.
  • Stanley-Laman Group's NCI, Inc. position peaked at $671K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held NCI, Inc. as of Q3 2017.

Based on Stanley-Laman Group's 13F filing for Q3 2017, filed 13 Nov 2017.